Evidence map›Paper›PMID 38287111›Full record

ArticleEye (London, England)2024

Innate immune responsive inflammation in development of progressive myopia.

Suqi Pan, Jianshu Yuan, Yuanhui Jin, Xiaotian Liu, Shanjun Wu, Yuwen Wang, Hongyan Yao, Lingyun Cheng

Open access · greenAbstract read
In one paragraph

Article in Eye (London, England), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
9.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 17 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. The role of inflammation in myopic retinopathy.Frontiers in ophthalmology · 2025
    Review
  9. Article
  10. Article
  11. Molecular changes in intraocular fluid: implications for myopia.International journal of biological sciences · 2024
    Review
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Suqi Pan *The Affiliated Ningbo Eye Hospital of Wenzhou Medical University, Ningbo, China.ORCID http://orcid.org/0000-0001-5475-7357
Jianshu Yuan *The Affiliated Ningbo Eye Hospital of Wenzhou Medical University, Ningbo, China.
Yuanhui JinDepartment of Ophthalmology, Dongyang People's Hospital, Dongyang, China.
Xiaotian LiuThe Affiliated Ningbo Eye Hospital of Wenzhou Medical University, Ningbo, China.
Shanjun WuThe Affiliated Ningbo Eye Hospital of Wenzhou Medical University, Ningbo, China.
Yuwen WangThe Affiliated Ningbo Eye Hospital of Wenzhou Medical University, Ningbo, China.
Hongyan YaoThe Affiliated Ningbo Eye Hospital of Wenzhou Medical University, Ningbo, China.
Lingyun ChengJacob's Retina Center at Shiley Eye Institute, Department of Ophthalmology, University of California San Diego, La Jolla, CA, USA. l1cheng@health.ucsd.edu.ORCID http://orcid.org/0000-0002-0748-5173
Wenzhou Medical University · CNUniversity of California San Diego · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeInflammation has been implicated for development of myopia. It is not clear when inflammation is kicked in during the course of myopia, and what characteristics of the inflammation. In this study, we tested for cytokines from aqueous humour of eyes with wide spectrum of refractive status for profiling the inflammation.

methodsAqueous humour of 142 patient eyes were tested for soluble intercellular adhesion molecule 1 (sICAM-1), monocyte chemoattractant protein-1 (MCP-1), and transforming growth factor-beta 2 (TGF-β2) using an enzyme-linked immunosorbent assay (ELISA). Eye globe axial length of these patients ranged from emmetropia to high myopia.

resultsOf 142 patients, an average axial length is 25.51 ± 3.31 mm, with a range of 21.56-34.37 mm. There are 36 cases in lower 25 percentile, 37 cases in upper 25 percentile, and 69 case in the middle 50 percentile. sICAM-1 and MCP-1 were significantly higher in the eyes with staphyloma (407.48 pg/mL, 312.31 pg/mL, n = 33) or macular schisis (445.86 pg/mL,345.33 pg/mL, n = 19) than that in the eyes without these changes (206.44 pg/mL, 244.76 pg/mL, n = 107). All three cytokines level was significantly associated with eye globe axial in a positive mode while adjusting for the age and sex. Strength of the association was the greatest for sICAM-1 and the weakest for TGF- β2. MCP-1 was in between.

conclusionsICAM-1 and MCP-1 in ocular fluid may be indicative biomarkers for progressive high myopia and the underneath autoimmune inflammation. sICAM-1 may be used as a monitoring biomarker for development of pathologic myopia.

Indexed as

Aqueous HumorChemokine CCL2Enzyme-Linked Immunosorbent AssayInflammationIntercellular Adhesion Molecule-1Myopia, DegenerativeTransforming Growth Factor beta2AdolescentAdultAxial Length, EyeBiomarkersChildCytokinesDisease ProgressionFemaleHumansBiomarkersCCL2 protein, humanChemokine CCL2CytokinesICAM1 protein, humanIntercellular Adhesion Molecule-1TGFB2 protein, humanTransforming Growth Factor beta2

Identifiers

PMID38287111
PMCPMC11126664
OpenAlexW4391305211

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.